Heterotopic caval valve implantation for the management of severe tricuspid regurgitation: a case series.

Aidan Sharkey Ronny Munoz Acuna Kiran BelaniRavi K SharmaOmar ChaudharyHuma FatimaRoger J LahamFeroze Mahmood

Published in: European heart journal. Case reports (2020)

Selective use of heterotopic CAVI to treat symptomatic severe TR that is refractory to medical therapy may be a viable option to improve symptoms in those patients that are unsuitable for surgical intervention.

Keyphrases

aortic valve
aortic stenosis
ejection fraction
mitral valve
end stage renal disease
randomized controlled trial
early onset
newly diagnosed
healthcare
prognostic factors
heart failure
inferior vena cava
left ventricular
coronary artery disease
physical activity
mesenchymal stem cells
patient reported